Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Mol Psychiatry. 2022 Apr 26;27(9):3633–3646. doi: 10.1038/s41380-022-01570-2

Figure 1: Perturbation of the epitranscriptome is associated with neuropsychiatric disorders and neurodegenerative diseases.

Figure 1:

Neuropsychiatric disorders share common variant risks, whereas neurodegenerative diseases appear more distinct from one another and from the neuropsychiatric disorders. Summary of RNA modifications associated with neuropsychiatric disorders and neurodegenerative diseases.